Attrition during neoadjuvant chemotherapy for gastric adenocarcinoma is associated with decreased survival: A United States Safety-Net Collaborative analysis.

Joshua P Kronenfeld Amber L Collier Michael K Turgeon Michelle R Ju Rodrigo E AlterioAnnie WangManuel FernandezMatthew R Porembka Harry RichterAnn Y LeeMaria C Russell Nipun B Merchant Ajay V Maker Jashodeep Datta

Published in: Journal of surgical oncology (2021)

Attrition during NAC for nonmetastatic GC is independently associated with worse OS, even in patients undergoing surgery. Attrition during NAC may reflect unfavorable tumor biology not captured by conventional staging metrics.

Keyphrases

neoadjuvant chemotherapy
locally advanced
lymph node
patients undergoing
transcription factor
sentinel lymph node
minimally invasive
squamous cell carcinoma
rectal cancer
coronary artery bypass
radiation therapy
pet ct
genome wide analysis
quality improvement
surgical site infection
atrial fibrillation